Oct 21, 2014 8:05am EDT Immunovaccine Demonstrates Protection Against Lethal Anthrax Challenge With Rapid Acting, Single Dose Vaccine
Oct 06, 2014 8:05am EDT Immunovaccine to Provide Update on Ongoing Ebola Virus and Cancer Vaccine Programs at 13th Annual BIO Investor Forum
Oct 01, 2014 8:05am EDT Immunovaccine Announces Plans for Phase II Clinical Trial of DPX-Survivac in Patients with Recurrent Lymphoma
Sep 26, 2014 8:05am EDT Immunovaccine Adds Broad Business Operations and Capital Raising Expertise to Board of Directors with New Appointments
Aug 25, 2014 10:30am EDT Ebola Vaccine Using Immunovaccine's DepoVax Proves Highly Efficacious in Non-Human Primate Study
Aug 12, 2014 8:05am EDT Immunovaccine to Present at Ninth Annual Immunotherapies and Vaccines Summit (ImVacS) Conference
Jun 02, 2014 8:05am EDT Immunovaccine Reports Promising Clinical Activity for Novel T Cell Activating Immunotherapy DPX-Survivac at ASCO 2014
